ERBB2 and breast carcinoma: In fact, its key role is demonstrated by its up-regulation after treatment with Lapatinib which, together with the rewiring of different signaling networks, and the inhibition of the HER2 signaling pathway, promotes cell survival and migration in breast cancer cell lines27,28.